The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer

British Journal of Cancer

Volumn 76, Issue 4, 1997, Pages 486-493

  Nooter, K ^a,c   Brutel De La Riviere, G ^a   Look, M P ^a   Van Wingerden, K E ^a   Henzen Logmans, S C ^a   Scheper, R J ^b   Flens, M J ^b   Klijn, J G M ^a   Stoter, G ^a   Foekens, J A ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Disease free survival; Immunohistochemical staining; Multidrug resistance associated protein; Overall survival; Prognostic significance

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; GLYCOPROTEIN P; METHOTREXATE; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL MEMBRANE; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; STATISTICAL ANALYSIS; TREATMENT FAILURE; TUMOR VOLUME;

EID: 8544241727     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.414     Document Type: Article

References (43)

1. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036-5040
2. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA and Kruh GD (1995) Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342-5347
3. Burger H, Nooter K, Zaman GJR, Sonneveld P, Van Wingerden K, Oostrum RG and Stoter G (1994a) Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 8: 990-997
4. Burger H, Nooter K, Sonneveld P, Van Wingerden K, Zaman GJR and Stoter G (1994b) High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukemia. Br J Haematol 88: 348-356
5. Childs S and Ling V (1994) The MDR superfamily of genes and its biological implications. In Important Advances in Oncology 1994, DeVita VT, Hellman S and Rosenberg SA. (eds), pp. 21-36. Lippincott: Philadelphia
6. Clynes M (1993) Multiple Drug Resistance in Cancer. Cellular, Molecular and Clinical Approaches. Kluwer: Dordrecht
7. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
8. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumour cells. Cancer Res 54: 5902-5910
9. Doyle AL (1993) Mechanisms of drug resistance in human lung cancer. Semin Oncol 20: 326-337
10. Endo K, Machara Y, Ichiyoshi Y, Kusumoto T, Sakaguchi Y, Ohno S and Sugimachi K (1996) Multidrug resistance-associated protein expression in clinical gastric carcinoma. Cancer 77: 1681-1687
11. EORTC Breast Cancer Cooperative Group (1980) Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515
12. Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D and Pirker R (1996) MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res 2: 1231-1237
13. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ and Zaman GJR (1994) Immunochemical detection of multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 54: 4557-4563
14. Flens MJ, Zaman GJR, Van Der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, Van Der Groep P, De Haas M, Meijer CJLM and Scheper RJ (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148: 1237-1247
15. Foekens JA, Portengen H, Van Putten WLJ, Peters HA, Krijnen HLJM, Alexieva-Figusch J and Klijn JGM (1989) Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res 54: 5823-5828
16. Goldstein LJ and Ozols RF (1994) Anticancer Drug Resistance: Advances in Molecular and Clinical Research. Kluwer: Boston
17. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361
18. Harris JR, Lippman ME, Veronesi U and Willett W (1992) Breast cancer. N Engl J Med 327: 319-328, 390-398, 473-480
19. Henderson IC, Harris JR, Kinne DW and Hellman S (1989) Cancer of the breast. In Cancer, Principles and Practice of Oncology, Devita VT, Hellman S and Rosenberg SA. (eds), pp. 1197-1268. Lippincott: Philadelphia
20. Hipfner DR, Gauldie SD, Deeley RG and Cole SPC (1994) Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 54: 5788-5792
21. Kaplan EL and Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
22. Kavallaris M, Leary JA, Barrett JA and Friedlander ML (1996) MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. Cancer Lett 102: 7-16
23. Klijn JGM, Berns EMJJ, Bontebal M and Foekens J (1993) Cell biological factors associated with the response of breast cancer to systemic treatment. Cancer Treat Rev 19: 45-63
24. Krishnamachary N and Center MS (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661
25. Kruh GD, Chan A, Myers K, Gaughan K, Miki T and Aaronson SA (1994) Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 54: 1649-1652
26. Kuss BJ, Deeley RG, Cole SPC, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA and Callen DF (1994) Deletion of gene for multidrug resistance in acute myeloid leukemia with inversion in chromosome 16: prognostic implications. Lancet 343: 1531-1534
27. Kuttesch JF, Parham DM, Luo X, Meyer WH, Bowman L, Shapiro DN, Pappo AS, Crist WM, Beck WT and Houghton PJ (1996) P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma. J Clin Oncol 14: 886-900
28. Lai SL, Goldstein LJ, Gottesman MM, Pastan I, Tsai CM, Johnson BE, Mulshine JL, Ihde DC, Kayser K and Gazdar AF (1989) MDR1 gene expression in lung cancer. J Natl Cancer Inst 81: 1144-1150
29. Linn SC, Giaccone G, Van Diest PJ, Blokhuis WMD, Van Der Valk P, Van Kalken CK, Kuiper CM, Pinedo HM and Baak JPA (1995) Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 6: 674-685
30. McGuire WL and Clark GM (1992) Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761
31. Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AV and McGuire WL (1989) Elcetrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or amplification. J Clin Oncol 7: 1129-1136
32. Nooter K and Sonneveld P (1994) Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Res 18: 233-243
33. Nooter K, Westerman A, Flens MJ, Zaman GJR, Scheper RJ, Van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratama JW, Kok T, Eggermont AMM, Bosman FT and Stoter G (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310
34. Nooter K, Bosman FT, Burger H, Van Wingerden KE, Flens MJ, Scheper RJ, Oostrum RG, Boersma AWM, Van Der Gaast A and Stoter G (1996a). Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung camcer. Ann Oncol 7: 75-81
35. Nooter K, Burger H and Stoter G (1996b) Multidrug resistance-associated protein (MRP) in haematological malignancies. Leuk Lymphoma 20: 381-387
36. Ota E, Abe Y, Oshika Y, Ozeki Y, Iwasaki M, Inoue H, Yamazaki H, Ueyama Y, Takagi K, Ogata T, Tamaoki N and Nakamura M (1995) Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 72: 550-554
37. Paul S, Breuninger LM, Tew KD, Shell H and Kruh GD (1996) ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proc Natl Acad Sci USA 93: 6929-6934
38. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ and Kaufmann SH (1995) Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85: 186-193
39. Thomas GA, Barrand MA, Stewart S, Rabbitts PH, Williams ED and Twentyman PR (1994) Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissues as determined by in situ hybridisation. Eur J Cancer 30A: 1705-1709
40. Tobe SW, Noble-Topham SE, Andrulis IL, Warren R, Hartwick J, Skorecki KL and Warner E (1995) Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumour histology, grade, and staging. Clin Cancer Res 1: 1611-1615
41. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB and Coon JS (1991) Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726
42. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, De Haas M, Smith AJ, Broxterman HJ, Mulder NH, De Vries EGE, Baas F and Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750
43. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826